WHO Drug Information - Volume 37, No. 4

Overview

The fourth issue of Volume 37, includes

Consultation Documents:

• IAEA/WHO Good manufacturing practices for in-house cold kits for radiopharmaceutical preparations
• WHO Biowaiver project – prioritization exercise of Active Pharmaceutical Ingredients for cycle VI (2024) and preliminary results for cycle V (2023)
• Fludeoxyglucose (18F) injection (Fludeoxyglucosi (18F) solution injectabilis)

ATC/DDD Classification:

• ATC/DDD Classification (Temporary)
• ATC/DDD Classification (Final)

The fourth issue of Volume 37, concludes with:

International Nonproprietary Names (INN) Proposed List No. 130